| SWKS |
Report |
Revenue (Q3 FY26, June q)) |
BEAT |
pred ~$940M vs. cons $928M |
MEDIUM |
| SWKS |
Report |
Non-GAAP EPS (Q3 FY26) |
BEAT |
pred ~$1.09 vs. cons $1.05 |
MEDIUM |
| SWKS |
Report |
Non-GAAP Gross Margin (Q3 FY26) |
IN-LINE |
pred ~45.2% vs. cons 45.0% |
MEDIUM |
| SWKS |
Guide |
Q4 FY26 (Sept) Revenue guide — the real event |
LOWER |
guide ~$1.00B vs. cons $1.03B (Q4 FY26, Sept qtr) |
MEDIUM |
| SWKS |
Guide |
Q4 FY26 Non-GAAP EPS guide |
LOWER |
guide ~$1.18 vs. cons $1.24 (Q4 FY26, Sept qtr) |
MEDIUM |
| SWKS |
Guide |
Q4 FY26 Gross Margin guide |
UNCHANGED |
guide ~45.5% vs. cons 46.0% (Q4 FY26, Sept qtr) |
LOW |
| SWKS |
Guide |
Qorvo merger timing (late-2026 vs early-2027 close) |
UNKNOWN |
reiterate ~early-2027 target vs. bull hope ~late-2026 (SAMR Phase 2 / FTC 2nd request pending) |
MEDIUM |
| SWKS |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.0% |
— |
LOW |
| SWKS |
Return |
5-day cumulative residual |
+0.5% (STABILIZE) |
SWKS trades as a merger-arb name pinned to QRVO via the 0.960x + $32.50 exchange ratio (~4% spread), which dampens idiosyncratic reaction to the print. A modest June-quarter beat is offset by a soft September (out-period) guide that pulls FY estimates lower, so any day-1 pop mean-reverts and the stock re-anchors to deal probability/timing rather than fundamentals. |
LOW |